8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001213900-25-060352
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea0247670-8k_oruka.htm…